HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianluca Sgarbi Selected Research

Neuropathy ataxia and retinitis pigmentosa

8/2009Human NARP mitochondrial mutation metabolism corrected with alpha-ketoglutarate/aspartate: a potential new therapy.
7/2008The study of the pathogenic mechanism of mitochondrial diseases provides information on basic bioenergetics.
5/2006Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in mtDNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianluca Sgarbi Research Topics

Disease

6Hypoxia (Hypoxemia)
01/2021 - 06/2010
5Neoplasms (Cancer)
01/2021 - 06/2011
4Mitochondrial Diseases (Mitochondrial Disease)
09/2020 - 07/2004
3Neuropathy ataxia and retinitis pigmentosa
08/2009 - 05/2006
2Osteosarcoma (Osteogenic Sarcoma)
06/2018 - 03/2015
2Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
05/2005 - 07/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2002 - 02/2002
1Hypothermia
01/2022
1Starvation
11/2020
1Adenocarcinoma of Lung
11/2020
1Neoplasm Metastasis (Metastasis)
11/2020
1Cardiomyopathies (Cardiomyopathy)
09/2020
1Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy)
12/2018
1Heart Diseases (Heart Disease)
01/2018
1Ventricular Dysfunction
01/2018
1Adenocarcinoma
11/2016
1Rhabdomyosarcoma
11/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2016
1Disease Progression
02/2016
1Carcinogenesis
04/2014
1Maternally Inherited Leigh Syndrome
08/2009
1Leigh Disease (Leigh's Disease)
05/2006
1Nervous System Diseases (Neurological Disorders)
05/2006
1MELAS Syndrome (Syndrome, MELAS)
07/2004

Drug/Important Bio-Agent (IBA)

8Adenosine Triphosphate (ATP)IBA
01/2021 - 05/2005
7Mitochondrial DNA (mtDNA)IBA
12/2018 - 07/2004
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 06/2010
3Proteins (Proteins, Gene)FDA Link
06/2018 - 06/2010
3Adenosine Triphosphatases (ATPase)IBA
03/2015 - 07/2008
2ResveratrolIBA
11/2019 - 12/2018
2Oxygen (Dioxygen)IBA
06/2018 - 06/2010
1Pharmaceutical PreparationsIBA
01/2022
1Adenosine Monophosphate (AMP)IBA
11/2020
1Adenylate KinaseIBA
11/2020
1Amino AcidsFDA Link
11/2020
1Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA
11/2020
1Serine (L-Serine)FDA Link
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2020
1CalciumIBA
09/2020
1Fluorescent Dyes (Fluorescent Probes)IBA
06/2018
1PolyphenolsIBA
01/2018
1TeaIBA
01/2018
1EnzymesIBA
03/2015
1Transcription Factors (Transcription Factor)IBA
04/2014
1Glucose (Dextrose)FDA LinkGeneric
07/2013
1A-factor (Streptomyces)IBA
07/2013
1Lactic Acid (Lactate)FDA LinkGeneric
06/2011
1Hypoxia-Inducible Factor 1IBA
06/2010
1Adenosine (Adenocard)FDA LinkGeneric
08/2009
1Proton-Translocating ATPases (ATPase, H+)IBA
07/2008
1Protons (Proton)IBA
05/2006
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
07/2004
1AntigensIBA
06/2002
1Oxidoreductases (Dehydrogenase)IBA
02/2002

Therapy/Procedure

1Therapeutics
02/2016